Kercheville Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-5,245
| Closed | -$397K | – | 111 |
|
|
2021
Q4 | $397K | Sell |
5,245
-1,040
| -17% | -$78.7K | 0.17% | 79 |
|
|
2021
Q3 | $703K | Buy |
6,285
+685
| +12% | +$76.6K | 0.33% | 63 |
|
|
2021
Q2 | $907K | Buy |
5,600
+95
| +2% | +$15.4K | 0.42% | 58 |
|
|
2021
Q1 | $663K | Sell |
5,505
-15
| -0.3% | -$1.81K | 0.33% | 67 |
|
|
2020
Q4 | $848K | Buy |
+5,520
| New | +$848K | 0.46% | 53 |
|